- 5.23 Peptide Hormones and the Design of Drugs for Hypertension
- Drug Design
- Selected References
- Immunomodulators and Their Receptors 6. Messenger Targets for Drug Action III:
- 6.1 Overview of the Immune System as a Source of Drug Targets
- 6.2 Design of Immunosuppressive Drugs
- 6.3 Design of Immunomodulating Drugs
- 6.4 The Clinical–Molecular Interface: Collagen Diseases
- Immunomodulators and Their Receptors 6. Messenger Targets for Drug Action III:
- Selected References
- Endogenous Cellular Structures 7. Nonmessenger Targets for Drug Action I:
- 7.1 Cellular Structures: Relevant Anatomy and Physiology
- 7.2 Targeting Cell Membrane Structures: Lipid Component
- 7.3 Targeting Cell Membrane Structures: Protein Component
- Ion Channels 7.4 Targeting Cell Membrane Proteins: Voltage-Gated
- 7.5 Targeting Cell Membrane Proteins: Ligand-Gated Ion Channels
- Transporter Proteins 7.6 Targeting Cell Membrane Proteins: Transmembrane
- 7.7 Targeting Cellular Cytoplasmic Structures
- 7.8 Targeting Cell Nucleus Structures
- Endogenous Cellular Structures 7. Nonmessenger Targets for Drug Action I:
- Selected References
- Endogenous Macromolecules 8. Nonmessenger Targets for Drug Action II:
- 8.1 Endogenous Macromolecules: Relevant Biochemistry
- 8.2 Proteins as Drugs and Drug Design Targets: Enzymes
- 8.3 Proteins as Drugs and Drug Design Targets: Non-Enzymes
- 8.4 Nucleic Acids as Drugs and Drug Design Targets
- 8.5 Lipids as Drugs and Drug Design Targets
- 8.6 Carbohydrates as Drugs and Drug Design Targets
- 8.7 Heterocycles as Drugs and Drug Design Targets
- 8.8 Inorganic Substances as Drugs and Drug Design Targets
- Endogenous Macromolecules 8. Nonmessenger Targets for Drug Action II:
- Selected References
- Exogenous Pathogens and Toxins 9. Nonmessenger Targets for Drug Action III:
- for Drug Design 9.1 Exogenous Pathogens as Targets
- 9.2 Drug Design Targeting Prions
- 9.3 Drug Design Targeting Viruses
- 9.4 Drug Design Targeting Bacteria
- 9.5 Drug Design Targeting Fungi
- 9.6 Drug Design Targeting Parasites
- 9.7 The Clinical–Molecular Interface: Pneumonia
- 9.8 The Clinical–Molecular Interface: Meningitis and Encephalitis
- 9.9 Drug Design of Therapies and Antidotes for Toxins
- Exogenous Pathogens and Toxins 9. Nonmessenger Targets for Drug Action III:
- Selected References
- Appendix: Drugs Arranged by Pharmacological Activity
- Index
jacob rumans
(Jacob Rumans)
#1